| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42806-513-30 | 42806-513 | HUMAN PRESCRIPTION DRUG | QUINIDINE SULFATE | quinidine sulfate tablet | TABLET | ORAL | 20220102 | N/A | ANDA | ANDA088072 | EPIC PHARMA, LLC | QUINIDINE SULFATE | 200 mg/1 | 30 TABLET in 1 BOTTLE (42806-513-30) |
| 42806-513-01 | 42806-513 | HUMAN PRESCRIPTION DRUG | QUINIDINE SULFATE | quinidine sulfate tablet | TABLET | ORAL | 20211215 | N/A | ANDA | ANDA088072 | EPIC PHARMA, LLC | QUINIDINE SULFATE | 200 mg/1 | 100 TABLET in 1 BOTTLE (42806-513-01) |
| 42806-512-30 | 42806-512 | HUMAN PRESCRIPTION DRUG | QUINIDINE SULFATE | quinidine sulfate tablet | TABLET | ORAL | 20220102 | N/A | ANDA | ANDA088072 | EPIC PHARMA, LLC | QUINIDINE SULFATE | 300 mg/1 | 30 TABLET in 1 BOTTLE (42806-512-30) |
| 42806-512-01 | 42806-512 | HUMAN PRESCRIPTION DRUG | QUINIDINE SULFATE | quinidine sulfate tablet | TABLET | ORAL | 20211215 | N/A | ANDA | ANDA088072 | EPIC PHARMA, LLC | QUINIDINE SULFATE | 300 mg/1 | 100 TABLET in 1 BOTTLE (42806-512-01) |
| 0185-1047-01 | 0185-1047 | HUMAN PRESCRIPTION DRUG | Quinidine Sulfate | Quinidine Sulfate | TABLET | ORAL | 19830926 | 20250531 | ANDA | ANDA088072 | Eon Labs, Inc. | QUINIDINE SULFATE | 300 mg/1 | 100 TABLET in 1 BOTTLE (0185-1047-01) |